Unknown PHASE4 INTERVENTIONAL 1-arm NCT05022628

Clinical Study of Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of Patients With HCC With Portal Vein Carcinoma Thrombosis

Sponsor: Anhui Provincial Hospital

Interventions Donafenib

Updated 4 times since 2021 Last updated: Sep 16, 2021 Started: Sep 30, 2021 Primary completion: Aug 31, 2023 Completion: Aug 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Chemotherapy Effect and HCC, this trial is ongoing. The trial is conducted by Anhui Provincial Hospital and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4

Status: Not Yet Recruiting → Unknown
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE4
Oct 2021 — Jul 2024 [monthly]

Not Yet Recruiting PHASE4
Sep 2021 — Oct 2021 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Anhui Provincial Hospital

Data source: Anhui Provincial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.